66.61
Schlusskurs vom Vortag:
$66.20
Offen:
$66.1
24-Stunden-Volumen:
458.93K
Relative Volume:
0.61
Marktkapitalisierung:
$1.95B
Einnahmen:
$427.54M
Nettoeinkommen (Verlust:
$-21.02M
KGV:
-89.77
EPS:
-0.742
Netto-Cashflow:
$14.26M
1W Leistung:
+11.74%
1M Leistung:
-24.40%
6M Leistung:
-44.58%
1J Leistung:
-16.76%
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
WGS
Genedx Holdings Corp
|
66.61 | 1.94B | 427.54M | -21.02M | 14.26M | -0.742 |
|
TMO
Thermo Fisher Scientific Inc
|
488.19 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
192.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
577.44 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
114.84 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
304.09 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
GeneDx Holdings Corp. (WGS) stock price, news, quote and history - uk.finance.yahoo.com
WGSWW SEC FilingsGeneDx Holdings Corp 10-K, 10-Q, 8-K Forms - Stock Titan
GeneDx CEO Sells Over $2.9 Million in Shares - National Today
Understanding Momentum Shifts in (WGS) - news.stocktradersdaily.com
GeneDx Holdings Corp. (WGS) latest stock news and headlines - Yahoo Finance Singapore
Cathie Wood’s ARK sells Strata Critical Medical stock, buys GeneDx Holdings - investing.com
WGS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 46,933 Shares - MarketBeat
New Strong Buy Stocks for April 2nd - The Globe and Mail
Investment Review: Can GeneDx Holdings Corp deliver alphaWeekly Trend Report & AI Enhanced Trading Signals - baoquankhu1.vn
WGS Stock Price, Quote & Chart | GENEDX HOLDINGS CORP (NASDAQ:WGS) - ChartMill
Book value per share of GeneDx Holdings Corp. – NASDAQ:WGS - TradingView
GeneDx stock rating reiterated at Overweight by Piper Sandler - Investing.com Canada
SG Americas Securities LLC Boosts Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx Holdings (WGS) Analyst Rating Update: Guggenheim Lowers P - gurufocus.com
GeneDx holdings CFO Feeley sells $557k in shares By Investing.com - Investing.com South Africa
GeneDx holdings CFO Feeley sells $557k in shares - investing.com
GeneDx (WGS) CFO exercises 16,250 RSUs, sells shares for taxes - Stock Titan
GeneDx (WGS) CEO exercises 80K RSUs, sells 47K shares for taxes - Stock Titan
GeneDx (NASDAQ:WGS) Stock Price Up 4.8%Still a Buy? - MarketBeat
WGSWW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Guggenheim Cuts GeneDx (NASDAQ:WGS) Price Target to $100.00 - MarketBeat
Decliners Report: Is GeneDx Holdings Corp stock forming a triangle pattern2026 Pullback Review & Weekly Top Performers Watchlists - baoquankhu1.vn
Momentum Shift: Is GeneDx Holdings Corp Equity Warrant stock showing strong momentum2026 Rallies & Smart Allocation Stock Reports - baoquankhu1.vn
Assessing GeneDx Holdings (WGS) Valuation After Recent Share Price Weakness - Yahoo Finance
Guidance Update: How does GeneDx Holdings Corp score in quality rankingsDip Buying & Weekly Return Optimization Alerts - baoquankhu1.vn
Moving Averages: How cyclical is GeneDx Holdings Corps revenue streamPortfolio Gains Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Can GeneDx (WGS) Turn Cost-Saving Genomics Into Durable Reimbursement Strength? - simplywall.st
Activity Recap: What is GeneDx Holdings Corp Equity Warrants valuation compared to sector2026 Setups & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Assenagon Asset Management S.A. Has $26.78 Million Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Craig-Hallum reaffirms buy on GeneDx (WGS) with $153 price target - MSN
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
GeneDx Holdings (WGS) upgraded to strong buy: Here's what you should know - msn.com
GENEDX HOLDINGS (WGS) Raised to Strong Buy: Essential Information You Need - Bitget
GeneDx Holdings Corp. (WGSWW) Stock Price, News, Quote & History - Yahoo! Finance Canada
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Craig-Hallum Reaffirms Buy on GeneDx (WGS) With $153 Price Target - Insider Monkey
Is GeneDx (WGS) Using Sponsored NPC Testing to Quietly Strengthen Its Data Advantage? - Yahoo Finance
10 Best Diagnostics and Research Stocks to Buy According to Analysts - Insider Monkey
Avoiding Lag: Real-Time Signals in (WGS) Movement - Stock Traders Daily
Is GeneDx Holdings (WGS) Attractive After Recent Share Price Weakness And DCF Upside? - simplywall.st
Published on: 2026-03-21 10:39:49 - baoquankhu1.vn
GeneDx (WGS), Zevra Therapeutics (ZVRA) partner to launch sponsored genetic testing program for NPC - MSN
GeneDx (WGS), Zevra Therapeutics (ZVRA) Partner to Launch Sponsored Genetic Testing Program for NPC - Insider Monkey
Jefferies reiterates GeneDx stock rating citing data advantage By Investing.com - Investing.com India
Jefferies reiterates GeneDx stock rating citing data advantage - Investing.com UK
GeneDx Holdings Corp. (WGS) Q4 earnings and revenues beat estimates - msn.com
GeneDx Holdings Corp (WGS) Stock Price Down 4.09% on Mar 18 - GuruFocus
What do analysts think about GeneDx Holdings Corp. (WGS)? - MSN
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 26 '26 |
Sale |
63.17 |
8,818 |
557,051 |
34,580 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Mar 26 '26 |
Option Exercise |
0.00 |
80,000 |
0 |
138,447 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Mar 26 '26 |
Sale |
63.17 |
46,933 |
2,964,841 |
91,514 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Mar 16 '26 |
Option Exercise |
0.00 |
18,750 |
0 |
75,626 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Mar 15 '26 |
Option Exercise |
0.00 |
11,921 |
0 |
56,876 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Mar 16 '26 |
Sale |
76.80 |
17,179 |
1,319,291 |
58,447 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 16 '26 |
Option Exercise |
0.00 |
7,197 |
0 |
32,854 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 15 '26 |
Option Exercise |
0.00 |
3,815 |
0 |
25,657 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 16 '26 |
Sale |
76.80 |
5,706 |
438,203 |
27,148 |
| Meister Keith A. | Director |
Mar 05 '26 |
Buy |
81.19 |
140,026 |
11,369,152 |
3,228,150 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):